William Anderson Raymond's most recent trade in Monopar Therapeutics Inc was a trade of 1,802 Common Stock done at an average price of $113.0 . Disclosure was reported to the exchange on Aug. 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Sale of securities on an exchange or to another person at price $ 113.05 per share. | 25 Aug 2026 | 1,802 | 23,751 (0%) | 0% | 113.0 | 203,716 | Common Stock |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Sale of securities on an exchange or to another person at price $ 113.05 per share. | 25 Aug 2026 | 1,802 | 5,373 (0%) | 0% | 113.0 | 203,716 | Common Stock |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.00 per share. | 25 Aug 2026 | 1,740 | 8,515 (0%) | 0% | 30 | 52,200 | Common Stock |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2026 | 1,740 | 3,480 | - | - | Stock Option | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.00 per share. | 25 Aug 2026 | 1,402 | 6,775 (0%) | 0% | 30 | 42,060 | Common Stock |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2026 | 1,402 | 2,803 | - | - | Stock Option | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Sale of securities on an exchange or to another person at price $ 110.04 per share. | 25 Aug 2026 | 694 | 26,169 (0%) | 0% | 110.0 | 76,368 | Common Stock |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Sale of securities on an exchange or to another person at price $ 110.04 per share. | 25 Aug 2026 | 694 | 7,821 (0%) | 0% | 110.0 | 76,368 | Common Stock |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Sale of securities on an exchange or to another person at price $ 110.07 per share. | 25 Aug 2026 | 646 | 25,523 (0%) | 0% | 110.1 | 71,105 | Common Stock |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Sale of securities on an exchange or to another person at price $ 111.07 per share. | 25 Aug 2026 | 646 | 7,175 (0%) | 0% | 111.1 | 71,751 | Common Stock |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2025 | 2,924 | 2,924 | - | - | Stock Options | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 11,365 | 11,365 | - | - | Stock Options | |
| Monopar Therapeutics Inc | William Anderson Raymond | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 2,533 | 26,863 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 2,533 | 0 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 2,534 | 5,066 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 2,534 | 21,797 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 2,533 | 19,263 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 2,533 | 7,600 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 13,930 | 13,930 | - | - | Stock Options | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 10,133 | 10,133 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 2,859 | 16,730 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 2,859 | 0 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2022 | 2,859 | 13,871 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2022 | 2,859 | 2,859 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 2,859 | 5,718 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 2,859 | 11,012 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 2,859 | 8,577 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Raymond William Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 2,859 | 8,153 (0%) | 0% | - | Common Stock |